한글목차

개요

유전체학 시장은 2023-2028년간 52억 1,000만 달러 확대되고, 예측 기간 중 연평균 복합 성장률(CAGR)은 3.16%를 나타낼 것으로 예측됩니다.

유전체학 시장에 대한 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 게재했습니다.

현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공합니다. 연구개발에 대한 투자 증가, 유전자 시퀀싱 비용 하락, 게놈 데이터베이스 작성과 업그레이드 요구 증가에 의해 시장 성장이 촉진되고 있습니다.

본 조사에서는 시퀀싱 기술 발전을 향후 몇 년간 유전체학 시장 성장을 촉진하는 주요인 중 하나로 특정하고 있습니다. 정밀의료나 유전자 치료의 발전과 확대, 소비자 직접거래에 의한 유전자 검사 수요 증가는 시장의 높은 수요로 연결될 것입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 구도

• 시장 생태계

제3장 시장 규모

• 시장의 정의
• 시장 부문 분석
• 시장 규모(2023년)
• 시장 전망(2023-2028년)

제4장 시장 규모 실적

• 세계의 유전체학 시장(2018-2022년)
• 솔루션별 부문 분석(2018-2022년)
• 용도별 부문 분석(2018-2022년)
• 지역별 부문 분석(2018-2022년)
• 국가별 부문 분석(2018-2022년)

제5장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁 위협
• 시장 현황

제6장 시장 세분화 : 솔루션별

• 시장 부문
• 비교 : 솔루션별
• 제품 : 시장 규모와 예측(2023-2028년)
• 서비스 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 솔루션별

제7장 시장 세분화 : 용도별

• 시장 부문
• 비교 : 용도별
• 진단 : 시장 규모와 예측(2023-2028년)
• Drug Discovery : 시장 규모와 예측(2023-2028년)
• 정밀의료 및 기타 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 용도별

제8장 고객 상황

• 고객 상황 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2023-2028년)
• 유럽 : 시장 규모와 예측(2023-2028년)
• 아시아 : 시장 규모와 예측(2023-2028년)
• 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
• 미국 : 시장 규모와 예측(2023-2028년)
• 영국 : 시장 규모와 예측(2023-2028년)
• 독일 : 시장 규모와 예측(2023-2028년)
• 프랑스 : 시장 규모와 예측(2023-2028년)
• 중국 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 지역 상황별

제10장 성장 촉진요인, 과제 및 동향

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 성장 촉진요인과 과제의 영향
• 시장 동향

제11장 벤더 구도

• 개요
• 벤더 구도
• 혼란 상황
• 업계 리스크

제12장 벤더 분석

• 대상 벤더
• 벤더의 시장 포지셔닝
• 10X Genomics Inc.
• Abcam plc
• Agilent Technologies Inc.
• Becton Dickinson and Co.
• BGI Group
• Bio Rad Laboratories Inc.
• Danaher Corp.
• Eppendorf SE
• F. Hoffmann La Roche Ltd.
• Illumina Inc.
• Myriad Genetics Inc.
• Oxford Nanopore Technologies plc
• Pacific Biosciences of California Inc.
• QIAGEN NV
• Standard BioTools Inc.

제13장 부록

영문목차

Abstract

The genomics market is forecasted to grow by USD 5.21 bn during 2023-2028, accelerating at a CAGR of 3.16% during the forecast period. The report on the genomics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising investments in genomics research and development, a reduction in the cost of genetic sequencing, and an increasing need to create and upgrade genome databases.

Technavio's genomics market is segmented as below:

By Solution

• Products
• Services

By Application

• Diagnostic
• Drug discovery
• Precision medicine and others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advances in sequencing technologies as one of the prime reasons driving the genomics market growth during the next few years. Also, growing developments in precision medicine and gene therapy and growing demand for direct-to-consumer genetic testing will lead to sizable demand in the market.

The report on the genomics market covers the following areas:

• Genomics market sizing
• Genomics market forecast
• Genomics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading genomics market vendors that include 10X Genomics Inc., Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., BGI Group, Bio Rad Laboratories Inc., Danaher Corp., Eppendorf SE, F. Hoffmann La Roche Ltd., Hamilton Bonaduz AG, Illumina Inc., Myriad Genetics Inc., New England Biolabs Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Promega Corp., QIAGEN NV, Standard BioTools Inc., Thermo Fisher Scientific Inc., and PerkinElmer Inc. Also, the genomics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Solution
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global genomics market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global genomics market 2018 - 2022 ($ billion)
• 4.2 Solution Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Solution Segment 2018 - 2022 ($ billion)
• 4.3 Application Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Solution

• 6.1 Market segments
• Exhibit 30: Chart on Solution - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Solution - Market share 2023-2028 (%)
• 6.2 Comparison by Solution
• Exhibit 32: Chart on Comparison by Solution
• Exhibit 33: Data Table on Comparison by Solution
• 6.3 Products - Market size and forecast 2023-2028
• Exhibit 34: Chart on Products - Market size and forecast 2023-2028 ($ billion)
• Exhibit 35: Data Table on Products - Market size and forecast 2023-2028 ($ billion)
• Exhibit 36: Chart on Products - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Products - Year-over-year growth 2023-2028 (%)
• 6.4 Services - Market size and forecast 2023-2028
• Exhibit 38: Chart on Services - Market size and forecast 2023-2028 ($ billion)
• Exhibit 39: Data Table on Services - Market size and forecast 2023-2028 ($ billion)
• Exhibit 40: Chart on Services - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Services - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Solution
• Exhibit 42: Market opportunity by Solution ($ billion)
• Exhibit 43: Data Table on Market opportunity by Solution ($ billion)

7 Market Segmentation by Application

• 7.1 Market segments
• Exhibit 44: Chart on Application - Market share 2023-2028 (%)
• Exhibit 45: Data Table on Application - Market share 2023-2028 (%)
• 7.2 Comparison by Application
• Exhibit 46: Chart on Comparison by Application
• Exhibit 47: Data Table on Comparison by Application
• 7.3 Diagnostic - Market size and forecast 2023-2028
• Exhibit 48: Chart on Diagnostic - Market size and forecast 2023-2028 ($ billion)
• Exhibit 49: Data Table on Diagnostic - Market size and forecast 2023-2028 ($ billion)
• Exhibit 50: Chart on Diagnostic - Year-over-year growth 2023-2028 (%)
• Exhibit 51: Data Table on Diagnostic - Year-over-year growth 2023-2028 (%)
• 7.4 Drug discovery - Market size and forecast 2023-2028
• Exhibit 52: Chart on Drug discovery - Market size and forecast 2023-2028 ($ billion)
• Exhibit 53: Data Table on Drug discovery - Market size and forecast 2023-2028 ($ billion)
• Exhibit 54: Chart on Drug discovery - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Drug discovery - Year-over-year growth 2023-2028 (%)
• 7.5 Precision medicine and others - Market size and forecast 2023-2028
• Exhibit 56: Chart on Precision medicine and others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 57: Data Table on Precision medicine and others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 58: Chart on Precision medicine and others - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Precision medicine and others - Year-over-year growth 2023-2028 (%)
• 7.6 Market opportunity by Application
• Exhibit 60: Market opportunity by Application ($ billion)
• Exhibit 61: Data Table on Market opportunity by Application ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 UK - Market size and forecast 2023-2028
• Exhibit 87: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 88: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 89: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.9 Germany - Market size and forecast 2023-2028
• Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.10 France - Market size and forecast 2023-2028
• Exhibit 95: Chart on France - Market size and forecast 2023-2028 ($ billion)
• Exhibit 96: Data Table on France - Market size and forecast 2023-2028 ($ billion)
• Exhibit 97: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on France - Year-over-year growth 2023-2028 (%)
• 9.11 China - Market size and forecast 2023-2028
• Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
• Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 105: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 107: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 108: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 109: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 110: Matrix on vendor position and classification
• 12.3 10X Genomics Inc.
• Exhibit 111: 10X Genomics Inc. - Overview
• Exhibit 112: 10X Genomics Inc. - Product / Service
• Exhibit 113: 10X Genomics Inc. - Key offerings
• 12.4 Abcam plc
• Exhibit 114: Abcam plc - Overview
• Exhibit 115: Abcam plc - Product / Service
• Exhibit 116: Abcam plc - Key news
• Exhibit 117: Abcam plc - Key offerings
• 12.5 Agilent Technologies Inc.
• Exhibit 118: Agilent Technologies Inc. - Overview
• Exhibit 119: Agilent Technologies Inc. - Business segments
• Exhibit 120: Agilent Technologies Inc. - Key offerings
• Exhibit 121: Agilent Technologies Inc. - Segment focus
• 12.6 Becton Dickinson and Co.
• Exhibit 122: Becton Dickinson and Co. - Overview
• Exhibit 123: Becton Dickinson and Co. - Business segments
• Exhibit 124: Becton Dickinson and Co. - Key news
• Exhibit 125: Becton Dickinson and Co. - Key offerings
• Exhibit 126: Becton Dickinson and Co. - Segment focus
• 12.7 BGI Group
• Exhibit 127: BGI Group - Overview
• Exhibit 128: BGI Group - Product / Service
• Exhibit 129: BGI Group - Key offerings
• 12.8 Bio Rad Laboratories Inc.
• Exhibit 130: Bio Rad Laboratories Inc. - Overview
• Exhibit 131: Bio Rad Laboratories Inc. - Business segments
• Exhibit 132: Bio Rad Laboratories Inc. - Key news
• Exhibit 133: Bio Rad Laboratories Inc. - Key offerings
• Exhibit 134: Bio Rad Laboratories Inc. - Segment focus
• 12.9 Danaher Corp.
• Exhibit 135: Danaher Corp. - Overview
• Exhibit 136: Danaher Corp. - Business segments
• Exhibit 137: Danaher Corp. - Key news
• Exhibit 138: Danaher Corp. - Key offerings
• Exhibit 139: Danaher Corp. - Segment focus
• 12.10 Eppendorf SE
• Exhibit 140: Eppendorf SE - Overview
• Exhibit 141: Eppendorf SE - Product / Service
• Exhibit 142: Eppendorf SE - Key news
• Exhibit 143: Eppendorf SE - Key offerings
• 12.11 F. Hoffmann La Roche Ltd.
• Exhibit 144: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 145: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 146: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 147: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 148: F. Hoffmann La Roche Ltd. - Segment focus
• 12.12 Illumina Inc.
• Exhibit 149: Illumina Inc. - Overview
• Exhibit 150: Illumina Inc. - Business segments
• Exhibit 151: Illumina Inc. - Key news
• Exhibit 152: Illumina Inc. - Key offerings
• Exhibit 153: Illumina Inc. - Segment focus
• 12.13 Myriad Genetics Inc.
• Exhibit 154: Myriad Genetics Inc. - Overview
• Exhibit 155: Myriad Genetics Inc. - Product / Service
• Exhibit 156: Myriad Genetics Inc. - Key offerings
• 12.14 Oxford Nanopore Technologies plc
• Exhibit 157: Oxford Nanopore Technologies plc - Overview
• Exhibit 158: Oxford Nanopore Technologies plc - Product / Service
• Exhibit 159: Oxford Nanopore Technologies plc - Key offerings
• 12.15 Pacific Biosciences of California Inc.
• Exhibit 160: Pacific Biosciences of California Inc. - Overview
• Exhibit 161: Pacific Biosciences of California Inc. - Product / Service
• Exhibit 162: Pacific Biosciences of California Inc. - Key offerings
• 12.16 QIAGEN NV
• Exhibit 163: QIAGEN NV - Overview
• Exhibit 164: QIAGEN NV - Product / Service
• Exhibit 165: QIAGEN NV - Key news
• Exhibit 166: QIAGEN NV - Key offerings
• 12.17 Standard BioTools Inc.
• Exhibit 167: Standard BioTools Inc. - Overview
• Exhibit 168: Standard BioTools Inc. - Product / Service
• Exhibit 169: Standard BioTools Inc. - Key news
• Exhibit 170: Standard BioTools Inc. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 171: Inclusions checklist
• Exhibit 172: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 173: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 174: Research methodology
• Exhibit 175: Validation techniques employed for market sizing
• Exhibit 176: Information sources
• 13.5 List of abbreviations
• Exhibit 177: List of abbreviations